These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 15651061

  • 1. Role of insulin-like growth factor binding proteins in 1alpha,25-dihydroxyvitamin D(3)-induced growth inhibition of human prostate cancer cells.
    Stewart LV, Weigel NL.
    Prostate; 2005 Jun 15; 64(1):9-19. PubMed ID: 15651061
    [Abstract] [Full Text] [Related]

  • 2. Castration-induced increases in insulin-like growth factor-binding protein 2 promotes proliferation of androgen-independent human prostate LNCaP tumors.
    Kiyama S, Morrison K, Zellweger T, Akbari M, Cox M, Yu D, Miyake H, Gleave ME.
    Cancer Res; 2003 Jul 01; 63(13):3575-84. PubMed ID: 12839944
    [Abstract] [Full Text] [Related]

  • 3. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
    Arnold JT, Le H, McFann KK, Blackman MR.
    Am J Physiol Endocrinol Metab; 2005 Mar 01; 288(3):E573-84. PubMed ID: 15536203
    [Abstract] [Full Text] [Related]

  • 4. IGF-I differentially regulates IGF-binding protein expression in primary mammary fibroblasts and epithelial cells.
    Fleming JM, Leibowitz BJ, Kerr DE, Cohick WS.
    J Endocrinol; 2005 Jul 01; 186(1):165-78. PubMed ID: 16002546
    [Abstract] [Full Text] [Related]

  • 5. Vitamin D-induced up-regulation of tumour necrosis factor alpha (TNF-alpha) in prostate cancer cells.
    Golovko O, Nazarova N, Tuohimaa P.
    Life Sci; 2005 Jun 17; 77(5):562-77. PubMed ID: 15904673
    [Abstract] [Full Text] [Related]

  • 6. Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models.
    Miyake H, Pollak M, Gleave ME.
    Cancer Res; 2000 Jun 01; 60(11):3058-64. PubMed ID: 10850457
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Differential regulation of IGFBP-3 by the androgen receptor in the lineage-related androgen-dependent LNCaP and androgen-independent C4-2 prostate cancer models.
    Kojima S, Mulholland DJ, Ettinger S, Fazli L, Nelson CC, Gleave ME.
    Prostate; 2006 Jun 15; 66(9):971-86. PubMed ID: 16541420
    [Abstract] [Full Text] [Related]

  • 9. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells.
    Gucev ZS, Oh Y, Kelley KM, Rosenfeld RG.
    Cancer Res; 1996 Apr 01; 56(7):1545-50. PubMed ID: 8603400
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The therapeutic and preventive effect of RRR-alpha-vitamin E succinate on prostate cancer via induction of insulin-like growth factor binding protein-3.
    Yin Y, Ni J, Chen M, DiMaggio MA, Guo Y, Yeh S.
    Clin Cancer Res; 2007 Apr 01; 13(7):2271-80. PubMed ID: 17404112
    [Abstract] [Full Text] [Related]

  • 12. Silibinin up-regulates insulin-like growth factor-binding protein 3 expression and inhibits proliferation of androgen-independent prostate cancer cells.
    Zi X, Zhang J, Agarwal R, Pollak M.
    Cancer Res; 2000 Oct 15; 60(20):5617-20. PubMed ID: 11059749
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of growth and regulation of IGFs and VEGF in human prostate cancer cell lines by shikonin analogue 93/637 (SA).
    Gaddipati JP, Mani H, Shefali, Raj K, Mathad VT, Bhaduri AP, Maheshwari RK.
    Anticancer Res; 2000 Oct 15; 20(4):2547-52. PubMed ID: 10953325
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Blockade of the type I IGF receptor expression in human prostate cancer cells inhibits proliferation and invasion, up-regulates IGF binding protein-3, and suppresses MMP-2 expression.
    Grzmil M, Hemmerlein B, Thelen P, Schweyer S, Burfeind P.
    J Pathol; 2004 Jan 15; 202(1):50-9. PubMed ID: 14694521
    [Abstract] [Full Text] [Related]

  • 16. Cell-associated insulin-like growth factor-binding proteins inhibit insulin-like growth factor-I-induced endometrial cancer cell proliferation.
    Bermont L, Fauconnet S, Lamielle F, Adessi GL.
    Cell Mol Biol (Noisy-le-grand); 2000 Nov 15; 46(7):1173-82. PubMed ID: 11075947
    [Abstract] [Full Text] [Related]

  • 17. Proliferation of DU145 prostate cancer cells is inhibited by suppressing insulin-like growth factor binding protein-2.
    Chatterjee S, Park ES, Soloff MS.
    Int J Urol; 2004 Oct 15; 11(10):876-84. PubMed ID: 15479293
    [Abstract] [Full Text] [Related]

  • 18. Insulin-like growth factor binding protein-3 induces early apoptosis in malignant prostate cancer cells and inhibits tumor formation in vivo.
    Devi GR, Sprenger CC, Plymate SR, Rosenfeld RG.
    Prostate; 2002 May 01; 51(2):141-52. PubMed ID: 11948969
    [Abstract] [Full Text] [Related]

  • 19. Castration-induced apoptosis of androgen-dependent shionogi carcinoma is associated with increased expression of genes encoding insulin-like growth factor-binding proteins.
    Nickerson T, Miyake H, Gleave ME, Pollak M.
    Cancer Res; 1999 Jul 15; 59(14):3392-5. PubMed ID: 10416600
    [Abstract] [Full Text] [Related]

  • 20. Hormonal regulation of IGFBP-2 proteolysis is attenuated with progression to androgen insensitivity in the LNCaP progression model.
    Degraff DJ, Malik M, Chen Q, Miyako K, Rejto L, Aguiar AA, Bancroft DR, Cohen P, Sikes RA.
    J Cell Physiol; 2007 Oct 15; 213(1):261-8. PubMed ID: 17492783
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.